Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of soluble urokinase plasminogen activator receptor levels to indicate prevention of cardiovascular disease with a statin

Use of soluble urokinase plasminogen activator receptor levels to indicate prevention of cardiovascular disease with a statin

US Patent 12498364 · Granted Dec 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

suPAR and prediction and treatment of acute kidney injury2025
Systems and methods for intrathecal delivery of a pharmaceutical agent2020